Molecular Signatures of Radiation Response in Breast Cancer: Towards Personalized Decision-Making in Radiation Treatment.

about

Molecular Signatures of Radiation Response in Breast Cancer: Towards Personalized Decision-Making in Radiation Treatment.

Item

http://www.wikidata.org/entity/Q48214148

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Molecular Signatures of Radiat ...... Making in Radiation Treatment.

@en

Molecular Signatures of Radiat ...... Making in Radiation Treatment.

@nl

type

Item

label

Molecular Signatures of Radiat ...... Making in Radiation Treatment.

@en

Molecular Signatures of Radiat ...... Making in Radiation Treatment.

@nl

prefLabel

Molecular Signatures of Radiat ...... Making in Radiation Treatment.

@en

Molecular Signatures of Radiat ...... Making in Radiation Treatment.

@nl

P1476

Molecular Signatures of Radiat ...... Making in Radiation Treatment.

@en

P2093

Lori J Pierce

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Utilization of genomic signatures to identify phenotype-specific drugs

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Identification of genes periodically expressed in the human cell cycle and their expression in tumors

Converting a breast cancer microarray signature into a high-throughput diagnostic test.

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.

P304

4279724

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/4279724

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Corey Speers

P577

2017-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29348942

http://www.w3.org/2001/XMLSchema#string

P932

5733757

http://www.w3.org/2001/XMLSchema#string